263 related articles for article (PubMed ID: 35718751)
1. Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia.
Wu KC; Chu PC; Cheng YJ; Li CI; Tian J; Wu HY; Wu SH; Lai YC; Kao HH; Hsu AL; Lin HW; Lin CH
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2073-2087. PubMed ID: 35718751
[TBL] [Abstract][Full Text] [Related]
2. Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles.
Fan M; Gu X; Zhang W; Shen Q; Zhang R; Fang Q; Wang Y; Guo X; Zhang X; Liu X
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2724-2739. PubMed ID: 36085573
[TBL] [Abstract][Full Text] [Related]
3. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
[TBL] [Abstract][Full Text] [Related]
4. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
5. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406
[TBL] [Abstract][Full Text] [Related]
6. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy.
Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
8. Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia.
Lu S; Li Y; Shen Q; Zhang W; Gu X; Ma M; Li Y; Zhang L; Liu X; Zhang X
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):779-795. PubMed ID: 33951335
[TBL] [Abstract][Full Text] [Related]
9. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
[TBL] [Abstract][Full Text] [Related]
10. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
Seto DN; Kandarian SC; Jackman RW
J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
[TBL] [Abstract][Full Text] [Related]
11. Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia.
Li B; Wan L; Li Y; Yu Q; Chen P; Gan R; Yang Q; Han Y; Guo C
Tumour Biol; 2014 Dec; 35(12):12415-25. PubMed ID: 25195133
[TBL] [Abstract][Full Text] [Related]
12. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation.
Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816
[TBL] [Abstract][Full Text] [Related]
13. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.
Aulino P; Berardi E; Cardillo VM; Rizzuto E; Perniconi B; Ramina C; Padula F; Spugnini EP; Baldi A; Faiola F; Adamo S; Coletti D
BMC Cancer; 2010 Jul; 10():363. PubMed ID: 20615237
[TBL] [Abstract][Full Text] [Related]
14. Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour-bearing mice.
Massart IS; Kouakou AN; Pelet N; Lause P; Schakman O; Loumaye A; Abou-Samra M; Deldicque L; Bindels LB; Brichard SM; Thissen JP
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):919-933. PubMed ID: 38572511
[TBL] [Abstract][Full Text] [Related]
15. IFIT2-depleted metastatic oral squamous cell carcinoma cells induce muscle atrophy and cancer cachexia in mice.
Lai KC; Hong ZX; Hsieh JG; Lee HJ; Yang MH; Hsieh CH; Yang CH; Chen YR
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1314-1328. PubMed ID: 35170238
[TBL] [Abstract][Full Text] [Related]
16. Babao Dan Alleviates Cancer Cachexia in Mice Via Inhibiting IL-6/STAT3 Signaling Pathway.
Qiu Z; Wo D; Zhong X; Chen J; Ma E; He J; Peng J; Zhu W; Ren DN
Integr Cancer Ther; 2023; 22():15347354231168369. PubMed ID: 37077153
[TBL] [Abstract][Full Text] [Related]
17. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
18. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
[TBL] [Abstract][Full Text] [Related]
19. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
20. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway.
Liu D; Qiao X; Ge Z; Shang Y; Li Y; Wang W; Chen M; Si S; Chen SZ
Skelet Muscle; 2019 Mar; 9(1):8. PubMed ID: 30922397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
